Clinical Trials
37
Active:7
Completed:19
Trial Phases
3 Phases
Phase 3:23
Phase 4:7
Not Applicable:5
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (35 trials with phase data)• Click on a phase to view related trials
Phase 3
23 (65.7%)Phase 4
7 (20.0%)Not Applicable
5 (14.3%)No trials found
News
Delhi High Court Grants Interim Injunction Against Zydus Biosimilar to Protect Nivolumab Patent Rights
The Delhi High Court granted an interim injunction restraining Zydus Lifesciences from manufacturing or launching its biosimilar ZRC-3276, which references Nivolumab (Opdivo) as the reference product.